Φορτώνει......
Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network
BACKGROUND: Duchenne muscular dystrophy (DMD) is the most commonly inherited neuromuscular disease. Therapeutic agents for the treatment of rare disease, namely “orphan drugs”, have recently drawn the attention of researchers and pharmaceutical companies. To ensure the successful conduction of clini...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | BMC Health Serv Res |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4939632/ https://ncbi.nlm.nih.gov/pubmed/27401940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-016-1477-4 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|